The problem: portal overload
The modern clinical desktop is a graveyard of open tabs. To answer a single complex question about a patient with comorbidities, a UK clinician might need to log into a local intranet for the antimicrobial policy, search NICE CKS for the primary care pathway, open the BNF for dosing, and check SIGN for a specific Scottish protocol.
This "portal overload" is a major driver of cognitive fatigue. The information exists, but the friction of accessing it—managing 10 tabs and 10 logins with no time to spare—is a safety risk.
The “front door” model
The solution is not another portal; it is an intelligent "AI Front Door." In this model, an AI assistant acts as the single entry point. It retrieves, reads, and organises the information for you. Crucially, the AI is not the source of truth; the primary sources (NICE, CKS, SIGN) remain the ground truth. The AI is simply a faster way to get to the right paragraph.
The UK source layer
No matter how good the AI, the underlying data must be authoritative. For UK practice, the non-negotiable source layer consists of:
- NICE: For national policy and comprehensive evidence reviews.
- NICE CKS: For pragmatic, primary-care focused management summaries.
- SIGN: For rigorous, evidence-based guidelines, particularly in Scotland.
AI layer comparison
iatroX (UK-Context + Citation-First)
- What it is: A UK-centric clinical AI assistant. It uses a "walled garden" approach, retrieving answers only from a curated list of UK-accepted sources like NICE, CKS, SIGN, and the BNF.
- Key features: It provides citation-first answers, meaning every claim is linked directly to the source document. It is designed for the NHS workflow, understanding local terminology and pathways. The platform states it is UKCA-marked and MHRA-registered for informational use.
- Best for: The daily "what do I do now?" questions where adherence to UK national guidance is essential.
OpenEvidence (Global Evidence + Literature)
- What it is: A powerful AI search engine grounded in peer-reviewed medical literature. It excels at synthesising complex evidence from journals like The Lancet, NEJM, and JAMA.
- Key features: It provides detailed answers with inline citations to the primary literature. Access is typically gated by NPI number for US clinicians, though it is expanding its partnerships.
- Best for: Deep dives into the evidence base, understanding the "why" behind a guideline, or researching conditions where UK guidance is silent.
How to use both without confusion
The key to a safe workflow is understanding the role of each tool:
- UK Default (iatroX): Use this for your routine clinical decisions. "What is the first-line antibiotic for a pregnant woman with a UTI?" iatroX will pull the specific NICE/BNF answer that keeps you compliant with UK safety standards.
- Global Evidence (OpenEvidence): Use this for "grey areas" or academic curiosity. "What is the latest trial data on SGLT2 inhibitors in non-diabetic kidney disease?" OpenEvidence will synthesise the global literature, giving you a broader perspective than a potentially older guideline.
The safe workflow template
- Ask: Input your natural language query into the AI front door (e.g., iatroX).
- Verify Citations: Don't just read the answer; click the citation link. Does the NICE CKS page actually say what the AI says it does?
- Apply: Use your clinical judgement to apply the guidance to your specific patient.
- Document: Record the primary source (e.g., "Management based on NICE NG123") in the patient's notes, not "AI told me."
FAQ
Can I trust an AI summary of a guideline? AI summaries are incredibly useful for speed, but they are not infallible. The "gold standard" is always the primary document. Use the AI to find the right section, but read the section yourself before making a critical decision.
Why use iatroX instead of just Googling NICE? Google prioritises SEO and often returns patient-facing pages or outdated PDFs. iatroX prioritises clinical relevance and extracts the specific actionable text, saving you clicks and reading time.
Is OpenEvidence available in the UK? OpenEvidence is primarily targeted at US healthcare professionals with NPI verification. However, it represents a class of "literature-grounded" tools that are valuable for research. UK clinicians should check current access requirements or use it as a benchmark for what high-quality evidence synthesis looks like.